Svensk version
Home
Patients & Public
PATIENTS & PUBLIC
THERAPY AREAS
MEDICAL CONTACTS
PATIENT ORGANIZATIONS
ORDERING PRODUCTS
OUR WEBSITES
Healthcare Professionals
HEALTHCARE PROFESSIONALS
PRODUCTS BY THERAPY AREA
PRODUCTS ALPHABETICAL LIST
MEDICAL CONTACTS
ORDERING PRODUCTS
OUR AFFILIATES & HEADQUARTERS
OUR WEBSITES
PRODUCT PIPELINE
PATIENT FOCUS
DEVELOPMENT PIPELINE
PRODUCT SUPPLY
BUSINESS DEVELOPMENT
PARTNERING
Investors & Media
INVESTORS & MEDIA
INTERIM & ANNUAL REPORTS
PRESENTATIONS
WEB & AUDIO CASTS
FINANCIAL CALENDAR
SHARE INFORMATION
PRESS RELEASES & NEWS
CORPORATE GOVERNANCE
BOARD OF DIRECTORS
SENIOR MANGEMENT
IMAGE BANK
RIGHTS ISSUE
CAPITAL MARKETS SEMINAR
About us
OUR COMPANY
VISION
MISSION & VALUES
WHY FOCUS ON RARE DISEASES
CORPORATE RESPONSIBILITY
BOARD OF DIRECTORS
SENIOR MANAGEMENT
CORPORATE GOVERNANCE
CAREERS
ALL CONTACTS
CALENDAR
You are here:
Start
|
Investors & Media
|
PRESS RELEASES & NEWS
INVESTORS & MEDIA
INTERIM & ANNUAL REPORTS
PRESENTATIONS
WEB & AUDIO CASTS
FINANCIAL CALENDAR
SHARE INFORMATION
PRESS RELEASES & NEWS
CORPORATE GOVERNANCE
BOARD OF DIRECTORS
SENIOR MANGEMENT
IMAGE BANK
RIGHTS ISSUE
CAPITAL MARKETS SEMINAR
Press Releases & News
Select year
2012-02-17 17:15
Sobi: Presentation of Q4 and Full Year 2011 results
2012-02-16 08:30
ReFacto AF®/XYNTHA® Supply Agreement Extended until 2020
2012-02-06 08:00
Sobi's agreement with Biogen Idec regarding long-lasting rFVIIIFc and rFIXFc hemophilia programs
2012-01-31 10:00
Sobi: Wills Hughes-Wilson appointed Vice President Government Affairs & Policy
2012-01-17 11:17
Alan Raffensperger appointed Chief Operating Officer
2012-01-13 08:30
Sobi signs global licensing agreement for novel neonatology treatment from Only for Children Pharmaceuticals
2012-01-10 18:00
Sobi presents today at J.P. Morgan Annual Healthcare Conference
More Press releases
Select year
2012-01-09 15:06
Gentium Appoints Swedish Orphan Biovitrum AB as Exclusive Distributor of Defibrotide in Nordic and Baltic Territories
2011-08-29 10:58
Pharming grants Sobi additional territories for the commercialization of Ruconest®
2011-01-27 13:06
Fresenius Biotech announcement regarding the agreement with Swedish Orphan Biovitrum for distribution of Removab®
2011-01-26 09:23
Sobi and Biogen Idec Hemophilia host symposium at EAHAD
2010-10-28 18:58
Pharming’s Ruconest™ For HAE Granted European Marketing Authorization
2010-11-29 11:48
Pharming Announces Topline Study Results On Prophylactic Use Of Ruconest In Hereditary Angioedema
2010-12-28 09:24
Swedish Orphan Biovitrum and Pharming Announce First Sales of Ruconest in Europe
More news